Application of Ga-PSMA-11 PET/CT in the Diagnosis of Prostate Cancer Clinical Relapse.

Background: This work aims to present a nuclear medicine imaging service's data regarding applying positron emission-computing tomography (PET/CT) scans with the radiopharmaceutical Ga-PSMA-HBED-CC (Ga-PSMA-11) to diagnose prostate cancer clinical relapse.

Methods: Eighty patients with a mean age of 68.26 years and an average prostatic-specific antigen blood level of 7.